+231.9%
ZETA vs MRNA
-10.0%
+241.9%
-70.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.4% | -2.2% | -6.2% | -8.2% |
| 7D | -19.5% | -12.7% | -6.8% | -18.5% |
| 30D | -13.5% | -20.7% | +7.2% | -11.9% |
| 3M | +6.0% | +46.3% | -40.3% | +1.4% |
| 6M | +60.9% | +305.2% | -244.3% | +24.1% |
| YTD | +45.0% | +561.2% | -516.2% | -0.3% |
| 1Y | +81.0% | +772.1% | -691.1% | +17.0% |
| 3Y | +243.9% | +147.0% | +97.0% | +160.0% |
| 5Y | +249.6% | -26.1% | +275.7% | +211.3% |
| All | +231.9% | -10.0% | +241.9% | +227.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling